Investigator and Biomechanics and Exercise Physiology Professor.
Head and full time Professor of Biomechanics and Exercise Physiology in the
Department of Health Sciences of the Public University of Navarra.
Professor of Sport Biomechanics at the Centre of Studies of the Spanish
Former Head of the Unit of the Research, Studies and
Sport Medicine Center of the Government of Navarra from 2005-2010.
Principal investigator and collaborator in several EU- funded projects focused on frailty
and exercise: VIVIFRAIL to Promote and recommend changes in lifestyle associated with
physical exercise for frail patients at risk of functional decline and MID-FRAIL to test the
efficacy of a multimodal intervention in prefrail/frail older patients with type 2 diabetes. Actually
is involved in a H2020 funded project of the European Comission DIABFRAIL-LATAM. Actually
is collaborating with WHO in the implementation of an physical exercise program as a global
strategy of invervention in frailty and risk of falling prevention. His current research interests
include the neuromuscular biomechanics of muscle strength and power with special interest
in strength training in both the elite athlete and the aging human. Prof. Mikel Izquierdo has
published more than 310 original articles in peer-reviewed journals and have been supervisor
of more that 20 PhD students. Publications on PubMed: http://goo.gl/zaiGw8”
Multi-component physical exercise programs and, in particular, strength training are the most effective interventions for delaying disability and other adverse events. Likewise, their use has been proven in other fields frequently associated with this syndrome such as falls, cognitive deterioration and depression. The effects of exercise are potentially similar to those that can be achieved […]
Physical function (i.e. including several variables as Gait Speed, Balance, mobility and muscle strength) is currently being proposed as biomarkers of healthy-aging in humans, predictive of adverse health events, disability, and mortality, as well as, commonly used as functional outcomes for clinical trials. For these reasons, functional ability, retaining autonomy and independence as people age […]